Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 206
Immune Disorders Drugs 93
Genomics 93
Biopharmaceuticals 88
Drug Discovery 78
Biotechnology 58
Oncology Drugs 58
Clinical Trials 50
Musculoskeletal Disorders Drugs 48
Pharmaceuticals 45
Hematological Drugs 42
Biosimilars and Biosuperiors 37
Cardiovascular Drugs 34
Alzheimer's Disease Drugs 32
Allergy and Immunology 31
Infusions and Injectables 28
Optical Disorders Drugs 26
Infectious Diseases Drugs 25
Needles and Syringes 24
Respiratory Drugs 20
Mental Disorders Drugs 20
Gastrointestinal Drugs 19
Neurology 18
Drug Delivery 17
Immunosuppressive Drugs 17
Pharmaceutical Manufacturing 16
Hematology 15
Healthcare Services 14
Lymphoma Drugs 14
Analgesics 14
Endocrine and Metabolic Disorders Drugs 14
Psoriasis Drugs 14
Leukemia Drugs 12
Liver and Kidney Disorders Drugs 11
Optical 10
Diagnostics 10
Company Reports 8
Therapeutic Area 8
Pulmonary Medicine 8
Enzymes 8
Medical Devices 8
E-Healthcare 7
Dermatological Drugs 7
Schizophrenia Drugs 7
Pharmaceutical Intermediates 5
Hospital Management 5
Neurology Devices 5
Cardiology 5
Oncology 5
Proteomics 4
Stem Cells 4
Vaccines 4
Anxiety Drugs 4
Generic Drugs 3
Pharmacoeconomics 3
Lung Cancer Drugs 3
Diabetes Devices 3
Biomaterials 3
Biomarkers 3
Dermatology 3
Mental Health 3
Vitamins and Dietary Supplements 3
Laboratory Equipment 3
Gastroenterology 3
In Vitro Diagnostics 2
Managed Care 2
Skin Cancer Drugs 2
Nanomedicine 2
Anatomy 2
Asthma Drugs 2
Drugs by Therapeutic Area 1
Urology and Nephrology 1
Women's Health 1
Fertility Services 1
Breast Cancer Drugs 1
Prostate Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Medical Imaging 1
Orthopedic Devices 1
Infectious Disease Testing 1
Computed Tomography 1
Transdermal and Transmucosal Drug Delivery 1
Surgical Procedures 1
Surgical Devices 1
Contrast Media 1
Kidney Cancer Drugs 1
Antibiotics 1
Clinical Skills 1
Pediatrics 1
HIV/AIDS Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

1,094 Results (Page 6 of 55)
- Relevance
  Sort by

Alzheimer's Disease Treatment Global Market Report 2024

 Report
February 2024
250 Pages
Global

From

€4835EUR$5,000USD£4,081GBP

Rare Hemophilia Factor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
83 Pages
Global

From

€3500EUR$3,877USD£3,057GBP

Global Cancer Monoclonal Antibodies Market & Clinical Trial Insight 2024

 Clinical Trials
November 2018
1100 Pages
Global

From

€2901EUR$3,000USD£2,448GBP

Hematology Collaboration and Licensing Deals 2016-2024

 Report
April 2024
100 Pages
Global

From

€3863EUR$3,995USD£3,260GBP

Alzheimer's Therapeutics Market By Drug Class, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

 Report
September 2022
172 Pages
Global

From

€3452EUR$3,570USD£2,913GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cutaneous Lupus Erythematosus - Pipeline Insight, 2024

 Clinical Trials
April 2024
80 Pages
Global

From

€1450EUR$1,500USD£1,224GBP

Duchenne Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
366 Pages
Global

From

€2417EUR$2,500USD£2,040GBP

Alzheimer's Disease - Pipeline Insights, 2024

 Clinical Trials
June 2024
240 Pages
Global

From

€2901EUR$3,000USD£2,448GBP

Patch Pump Drug Delivery System Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
104 Pages
Global

From

€3500EUR$3,877USD£3,057GBP

Japan Alzheimer's Disease - Market Insight, Epidemiology and Market Forecast - 2032

 Report
January 2024
200 Pages
Japan

From

€5560EUR$5,750USD£4,693GBP

Musculoskeletal Collaboration and Licensing Deals 2016-2024

 Report
April 2024
250 Pages
Global

From

€3863EUR$3,995USD£3,260GBP

Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€1934EUR$2,000USD£1,632GBP

Gene Therapy Market by Type of Therapy, Type of Gene Delivery Method Used, Type of Vector Used, Target Therapeutic Areas, Route of Administration, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
June 2022
865 Pages
Global

From

€5704EUR$5,899USD£4,814GBP

Alzheimer's Disease - Market Insight, Epidemiology And Market Forecast - 2032

 Report
August 2023
255 Pages
Global

From

€9186EUR$9,500USD£7,753GBP

Alzheimer Drugs Market - Forecast (2022 - 2027)

 Report
February 2022
111 Pages
Global

From

€4351EUR$4,500USD£3,672GBP

Progressive Multifocal Leukoencephalopathy Treatment Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4835EUR$5,000USD£4,081GBP

Global Alzheimer's Treatment Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€5801EUR$5,999USD£4,896GBP

Antibody Drugs: Technologies and Global Markets 2021-2026

 Report
October 2021
133 Pages
Global

From

€2659EUR$2,750USD£2,244GBP

€5318EUR$5,500USD£4,489GBP

Autoinjectors: Intellectual Property Landscape, Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis

 Report
January 2023
205 Pages
Global

From

€1836EUR$1,899USD£1,550GBP

Acute Ischemic Stroke Diagnosis and Treatment - Global Strategic Business Report

 Report
May 2024
194 Pages
Global

From

€4786EUR$4,950USD£4,040GBP

1,094 Results (Page 6 of 55)
- 1
- 4
- 5
- 6
- 7
- 8

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.